...
首页> 外文期刊>The Journal of Physiology >Graded sympatholytic effect of exogenous ATP on postjunctional alpha-adrenergic vasoconstriction in the human forearm: implications for vascular control in contracting muscle.
【24h】

Graded sympatholytic effect of exogenous ATP on postjunctional alpha-adrenergic vasoconstriction in the human forearm: implications for vascular control in contracting muscle.

机译:外源ATP对人前臂结后α-肾上腺素能血管收缩的分级交感作用:对收缩肌肉中血管控制的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Recent evidence suggests that adenosine triphosphate (ATP) can inhibit vasoconstrictor responses to endogenous noradrenaline release via tyramine in the skeletal muscle circulation, similar to what is observed in contracting muscle. Whether this involves direct modulation of postjunctional alpha-adrenoceptor responsiveness, or is selective for alpha(1)- or alpha(2)-receptors remains unclear. Therefore, in Protocol 1, we tested the hypothesis that exogenous ATP can blunt direct postjunctional alpha-adrenergic vasoconstriction in humans. We measured forearm blood flow (FBF; Doppler ultrasound) and calculated the vascular conductance (FVC) responses to local intra-arterial infusions of phenylephrine (alpha(1)-agonist) and dexmedetomidine (alpha(2)-agonist) during moderate rhythmic handgrip exercise (15% maximum voluntary contraction), during a control non-exercise vasodilator condition (adenosine), and during ATP infusion in eight young adults. Forearm hyperaemia was matched across all conditions. Forearm vasoconstrictor responses to direct alpha(1)-receptor stimulation were blunted during exercise versus adenosine (DeltaFVC = -11 +/- 3% versus -39 +/- 5%; P< 0.05), and were abolished during ATP infusion (-3 +/- 2%). Similarly, vasoconstrictor responses to alpha(2)-receptor stimulation were blunted during exercise versus adenosine (-13 +/- 4% versus -40 +/- 8%; P< 0.05), and were abolished during ATP infusion (-4 +/- 4%). In Prototol 2 (n = 10), we tested the hypothesis that graded increases in ATP would reduce alpha(1)-mediated vasoconstriction in a dose-dependent manner compared with vasodilatation evoked via adenosine. Forearm vasoconstrictor responses during low dose adenosine (-38 +/- 3%) and ATP (-33 +/- 2%) were not significantly different from rest (-40 +/- 3%; P> 0.05). In contrast, vasoconstrictor responses during moderate (-22 +/- 6%) and high dose ATP (-8 +/- 5%) were significantly blunted compared with rest, whereas the responses during adenosine became progressively greater (moderate = -48 +/- 4%, P = 0.10; high = -53 +/- 6%, P< 0.05). We conclude that exogenous ATP is capable of blunting direct postjunctional alpha-adrenergic vasoconstriction, that this involves both alpha(1)- and alpha(2)-receptor subtypes, and that this is graded with ATP concentrations. Collectively, these data are consistent with the conceptual framework regarding how muscle blood flow and vascular tone are regulated in contracting muscles of humans.
机译:最近的证据表明,三磷酸腺苷(ATP)可以抑制骨骼肌循环中通过酪胺释放的内源性去甲肾上腺素对血管收缩剂的反应,与收缩肌肉时相似。目前尚不清楚这是否涉及结后α-肾上腺素受体反应性的直接调节,还是对α(1)-或α(2)-受体的选择性。因此,在方案1中,我们测试了外源ATP可以钝化人类直接结后α-肾上腺素能血管收缩的假说。我们测量了前臂的血流量(FBF;多普勒超声),并计算了在中等节律性抓握过程中对局部去氧苯肾上腺素(α(1)-激动剂)和右美托咪定(α(2)-激动剂)进行局部动脉内输注的血管传导(FVC)运动(在控制性非运动性血管扩张药(腺苷)期间)以及在ATP输注过程中的八名年轻人(最大自愿收缩量为15%)。前臂充血在所有情况下均匹配。与腺苷相比,运动过程中前臂对直接α(1)-受体刺激的血管收缩反应减弱(DeltaFVC = -11 +/- 3%对-39 +/- 5%; P <0.05),而在ATP输注期间被消除(- 3 +/- 2%)。同样,运动期间与腺苷相比,对α(2)-受体刺激的血管收缩反应减弱(-13 +/- 4%对-40 +/- 8%; P <0.05),而在ATP输注过程中消失(-4 + /-4%)。在Prototol 2(n = 10)中,我们测试了以下假设:与通过腺苷引起的血管舒张相比,ATP的分级增加将以剂量依赖的方式减少alpha(1)介导的血管收缩。低剂量腺苷(-38 +/- 3%)和ATP(-33 +/- 2%)时的前臂血管收缩反应与静息时无显着差异(-40 +/- 3%; P> 0.05)。相反,与静息相比,中度(-22 +/- 6%)和高剂量ATP(-8 +/- 5%)期间的血管收缩反应明显减弱,而腺苷期间的血管收缩反应逐渐增强(中度= -48 + +/- 4%,P = 0.10;高= -53 +/- 6%,P <0.05)。我们得出的结论是,外源性ATP能够减弱直接的结后α-肾上腺素能血管收缩,这涉及α(1)-和α(2)-受体亚型,并且这与ATP浓度有关。总的来说,这些数据与关于在人类的收缩肌肉中如何调节肌肉血流和血管紧张度的概念框架相一致。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号